Naproxen Krka (Naproxen Sodium)

Naproxen sodium, the active ingredient in Naproxen Krka, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is employed to relieve mild to moderate pain, diminish inflammation, and lower fever in adult patients with conditions such as arthritis, dysmenorrhea, and gout.

GNH USA supplies Naproxen Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled manufacturing and reliable distribution across EU and global markets with comprehensive regulatory support and on‑time logistics.

Naproxen Krka, an NSAID, acts on inflammatory pathways to provide analgesic and antipyretic effects. - Mild to moderate pain: alleviates headaches, dental pain, musculoskeletal aches, and postoperative discomfort. - Rheumatoid arthritis: reduces joint inflammation, swelling, and stiffness, improving mobility. - Osteoarthritis: diminishes chronic joint pain and inflammation associated with degenerative cartilage loss. - Dysmenorrhea: eases menstrual cramps by decreasing uterine prostaglandin production. - Gout flares: relieves acute gouty arthritis pain and swelling.

Naproxen Krka may cause a range of adverse reactions, varying from mild and transient to serious but uncommon.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, abdominal pain or heartburn that may resolve with food. - Headache: mild to moderate intensity, often transient. - Dizziness or vertigo: sensation of light‑headedness or imbalance. - Mild skin reactions: rash, pruritus or localized erythema.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: severe stomach or intestinal ulcers that can cause hematemesis or melena. - Severe hypersensitivity reactions: including Stevens‑Johnson syndrome, toxic epidermal necrolysis, or anaphylaxis. - Renal impairment: acute kidney injury manifested by reduced urine output or elevated creatinine.

When prescribing or dispensing Naproxen Krka, consider the following precautions to minimize risk and ensure safe use. - Cardiovascular risk: avoid in patients with uncontrolled hypertension or recent myocardial infarction. - Gastrointestinal history: use with caution in individuals with a history of ulcers, bleeding, or chronic NSAID use. - Renal function: monitor kidney function in patients with pre‑existing renal disease or dehydration. - Concomitant anticoagulants: assess bleeding risk when combined with warfarin, aspirin, or other anticoagulants. - Pregnancy and lactation: evaluate benefits versus risks; avoid in late pregnancy unless essential. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Naproxen Krka can interact with several medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, direct oral anticoagulants): increased risk of serious bleeding. - Selective COX‑2 inhibitors (e.g., celecoxib): additive gastrointestinal toxicity. - Corticosteroids (e.g., prednisone): heightened chance of ulceration and bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs (e.g., lisinopril, losartan): may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics (e.g., furosemide): potential for decreased renal function and electrolyte imbalance. - Lithium: NSAIDs can raise lithium serum levels, risking toxicity.